FTC sues Enforma
This article was originally published in The Tan Sheet
Executive Summary
Civil contempt charges filed by FTC Jan. 3 against Enforma Natural Products; hearing is scheduled for Feb. 4 in Los Angeles federal court. Commission alleges Enforma "blatantly disregarded" a May 2000 order by continuing to make unsubstantiated claims about its Fat Trapper Plus and Exercise In A Bottle weight-loss products (1"The Tan Sheet" May 1, 2000, p. 17). FTC requests order requiring defendants cease use of trade names Fat Trapper, Fat Trapper Plus and Exercise in a Bottle, and turn over all gross revenues from sale of products at issue since May 2000...
You may also be interested in...
Enforma To Cease Deceptive Weight Loss Claims, Pay $10 Mil. -FTC
Enforma Natural Products settles Federal Trade Commission charges that it made false and unsubstantiated weight loss claims in an infomercial and on the Internet, without admitting a violation of law, the agency announces April 26.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.